Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCurrys Regulatory News (CURY)

Share Price Information for Currys (CURY)

Share Price is delayed by 15 minutes
Get Live Data
156.20    5.60 (3.72%)
Bid:
155.50
Ask:
155.70
Spread: 0.20 (0.129%)
Market Cap: £1.62b
CURY Live PriceLast checked at - London Stock Exchange

Intraday Currys Share Chart

Director/PDMR Shareholding

12 Aug 2025 14:41

RNS Number : 0382V
Currys PLC
12 August 2025
 

12 August 2025

CURRYS PLC

NOTIFICATION OF TRANSACTION OF DIRECTOR

Award under the 2022/23 Deferred Share Bonus Plan ("DSBP")

In accordance with the requirements of DTR 3.1 and Market Abuse Regulation Article 19, Currys plc (the 'Company') announces the following share transaction undertaken by Alex Baldock, Group Chief Executive (a PDMR).

Alex Baldock exercised nil cost options over ordinary shares of 0.1 pence in the Company in respect of the 2022/23 DSBP Award (the "Award") which was granted on the 3 August 2023 under the DSBP. The Award vested on 3 August 2025, and Alex subsequently exercised a total of 288,617 options and sold 136,128 shares to cover the tax liability arising on the transaction. The remaining 152,489 shares were retained.

PMDR DEALING NOTIFICATION

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Alex Baldock

2

Reason for the notification

a)

Position/status

Group Chief Executive

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer

a)

Name

Currys plc

b)

LEI

2138001E12GWLLDQQF16

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Ordinary shares of 0.1p each in Currys plc

Identification code

GB00B4Y7R145

b)

Nature of the transaction

Exercise of a share option under the Currys Deferred Share Bonus Plan and sale of shares to cover the tax and NIC arising from the exercise.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil cost

288,617

£1.131

136,128

 

 

d)

Aggregated information

-

Aggregated volume

-

Price

1. Exercise

Price(s)

Volume(s)

Total

Nil cost

288,617

 £0.00

 

2. Sale

Price(s)

Volume(s)

Total

£1.131

136,128

 £153,961

e)

Date of the transaction

(DD-MM-YYYY)

12-08-2025

f)

Place of the transaction

London Stock Exchange (XLON)

 

Enquiries:

 

Sarah Thomas Deputy Company Secretary +44 (0)7401 373 188

 

Dan Homan Investor Relations Director +44 (0)7401 400 442

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBXGDIGSBDGUD
Date   Source Headline
1st Apr 202510:30 amRNSTotal Voting Rights
18th Mar 20251:54 pmRNSHolding(s) in Company
12th Mar 202511:03 amRNSHolding(s) in Company
3rd Mar 20259:53 amRNSTotal Voting Rights
14th Feb 20252:23 pmRNSHolding(s) in Company
14th Feb 202511:10 amRNSDirector/PDMR Shareholding
3rd Feb 20259:47 amRNSTotal Voting Rights
29th Jan 202510:24 amRNSDirector/PDMR Shareholding
16th Jan 202511:30 amRNS-REngage Investor event
15th Jan 20254:54 pmRNSHolding(s) in Company
15th Jan 20257:00 amRNSStrong Peak trading and improved profit outlook
2nd Jan 20259:41 amRNSTotal Voting Rights
12th Dec 20247:00 amRNSH1 Results - Performance Continues to Strengthen
2nd Dec 202410:09 amRNSTotal Voting Rights
1st Nov 202410:28 amRNSTotal Voting Rights
30th Oct 20242:45 pmRNSHolding(s) in Company
8th Oct 202411:20 amRNSHolding(s) in Company
1st Oct 20242:20 pmRNSTotal Voting Rights
27th Sep 202410:17 amRNSHolding(s) in Company
26th Sep 202410:24 amRNSHolding(s) in Company
26th Sep 20247:00 amRNSNordic investor event
25th Sep 20249:21 amRNSHolding(s) in Company
23rd Sep 20243:04 pmRNSHolding(s) in Company
23rd Sep 20249:26 amRNSHolding(s) in Company
17th Sep 20243:39 pmRNSHolding(s) in Company
11th Sep 20249:20 amRNSHolding(s) in Company
10th Sep 20249:25 amRNSHolding(s) in Company
5th Sep 20242:25 pmRNSResult of AGM
5th Sep 20247:00 amRNSPositive start to the year
2nd Sep 202410:47 amRNSTotal Voting Rights
30th Aug 202411:04 amRNSDirector Declaration
30th Aug 20247:05 amRNSDirector Declaration
27th Aug 20249:31 amRNSHolding(s) in Company
22nd Aug 20249:20 amRNSHolding(s) in Company
1st Aug 20242:20 pmRNSDirector/PDMR Shareholding
1st Aug 20242:14 pmRNSDirector/PDMR Shareholding
1st Aug 20242:10 pmRNSDirector/PDMR Shareholding
1st Aug 20242:09 pmRNSDirector/PDMR Shareholding
1st Aug 202410:27 amRNSTotal Voting Rights
31st Jul 20249:29 amRNSHolding(s) in Company
25th Jul 202410:17 amRNSAnnual Financial Report
19th Jul 20243:59 pmRNSHolding(s) in Company
19th Jul 20241:02 pmRNSHolding(s) in Company
17th Jul 202412:15 pmRNSDirector/PDMR Shareholding
15th Jul 202410:37 amRNSHolding(s) in Company
12th Jul 20249:56 amRNSDirector Declaration
3rd Jul 20241:26 pmRNSDirector/PDMR Shareholding
2nd Jul 202411:20 amRNSHolding(s) in Company
1st Jul 20249:21 amRNSTotal Voting Rights
1st Jul 20249:13 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.